Target intelligence / Profile preview

Homeobox protein NANOGP8 (NANOGP8)

Target
NANOGP8
Molecular classification
Transcription factor, Homeobox protein, Retrogene
01

Overview

Homeobox protein NANOGP8 is a human retrogene and a functional paralog of the canonical pluripotency transcription factor NANOG. While NANOG is well-known for its role in embryonic stem cell self-renewal and maintenance of pluripotency, NANOGP8 is a single-exon, intronless retrogene that arose from NANOG and is uniquely capable among its pseudogene family of encoding a functional protein[2][3][7]. The NANOGP8 protein differs from NANOG by only a few amino acids and exhibits nearly identical reprogramming and DNA-binding activity[2][3]. Unlike NANOG, which is highly expressed in embryonic stem cells, NANOGP8 is predominantly and abundantly expressed in a variety of cancers, including glioblastoma multiforme, where it appears to replace or supplement the role of NANOG as a driver of cancer cell stemness, proliferation, and potentially tumorigenicity[1][2][3][7]. Its expression is often much greater than that of canonical NANOG in cancerous cells, making it a potential cancer stem cell marker and a subject of intense research interest for its fundamental and translational significance[1][2][7]. Due to extensive sequence similarity, accurate molecular distinction between NANOG and NANOGP8 requires careful primer and probe design[2]. Currently, no approved drugs selectively target NANOGP8, but its relevance as an oncogenic driver and cancer stem cell biomarker is increasingly recognized, especially in the context of aggressive brain tumors and other malignancies[1][7].

Other names
Nanog homeobox retrogene P8Homeobox protein NANOGP8Nanog-like proteinPutative homeobox protein NANOGP8PN8NANOGP1 (note: sometimes used interchangeably in literature, though strictly speaking, NANOGP1 is an earlier pseudogene; context-dependent)
02

Biological functions

Regulation of pluripotencyMaintenance of stemnessCell proliferation
03

Disease associations

CancerGlioblastoma multiforme (GBM)Other malignant tumors (including other solid cancers)
04

Safety considerations

Potential off-target effects due to high similarity to NANOG and presence in normal stem cellsRisk of affecting non-cancerous pluripotent cell populations if targeted
05

Biomarkers

Tumor cell marker (especially for certain cancer stem-like cells and in glioblastoma[1][7])Potential marker for cancer stem cell properties

Beyond the preview

Go deeper on Homeobox protein NANOGP8 (NANOGP8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Homeobox protein NANOGP8 (NANOGP8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call